CD8A and melanoma: Similar to the findings by Landsberg et al. in the HGF-CDK4 melanoma model, we found that B16.F10 tumors also develop resistance to gp100-specific CD8+ T cells due to downregulation of gp100 antigen expression caused by T-cell-derived cytokines22.